IMMUNOTHERAPY FOR HER2 POSITIVE BREAST CANCER

被引：0
|
作者：
Vaidya, T. R. [1 ]
Ait-Oudhia, S. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-003
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] Evaluating Trastuzumab in the treatment of HER2 positive breast cancer
    Jaques, Ryan
    Xu, Sam
    Matsakas, Antonios
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (10) : 1059 - 1075
  • [22] PREOPERATIVE SYSTEMIC THERAPY FOR HER2 POSITIVE BREAST CANCER
    Ueno, Takayuki
    ANNALS OF ONCOLOGY, 2014, 25
  • [23] Small HER2 Positive Breast Cancer: When is Enough?
    Singh, Randeep
    Gupta, Sudeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (01) : 1 - 3
  • [24] What therapies are on the horizon for HER2 positive breast cancer?
    Viale, Giulia
    Morganti, Stefania
    Ferraro, Emanuela
    Zagami, Paola
    Marra, Antonio
    Curigliano, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (09) : 811 - 822
  • [25] Novel therapies for metastatic HER2 positive breast cancer
    Cossetti R.J.D.
    Gelmon K.A.
    Current Breast Cancer Reports, 2013, 5 (4) : 331 - 340
  • [26] THE UPFRONT THERAPY FOR HER2 POSITIVE BREAST CANCER PATIENTS
    Iwata, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [27] Locoregional recurrence in patients with HER2 positive breast cancer
    Brollo, Janaina
    Kneubil, Maximiliano Cassilha
    Botteri, Edoardo
    Rotmensz, Nicole
    Duso, Bruno Achutti
    Fumagalli, Luca
    Locatelli, Marzia Adelia
    Criscitiello, Carmen
    Lohsiriwat, Visnu
    Goldhirsch, Aron
    Leonardi, Maria Cristina
    Orecchia, Roberto
    Curigliano, Giuseppe
    BREAST, 2013, 22 (05): : 856 - 862
  • [28] Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    Wahler J.
    Suh N.
    Current Pharmacology Reports, 2015, 1 (5) : 324 - 335
  • [29] Immune Effects of Transtuzumab in HER2 Positive Breast Cancer
    Zgura, Anca
    Gales, Laurentia
    Haineala, Bogdan
    Bratila, Elvira
    Mehedintu, Claudia
    Barac, Ramona Ileana
    Berceanu, Costin
    Andreescu, Cristina Veronica
    Brinduse, Lacramioara Aurelia
    Ionescu, Alec
    Anghel, Rodica
    REVISTA DE CHIMIE, 2019, 70 (08): : 2791 - 2794
  • [30] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
12345